FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Saturday

 

Have a Say About MS Drugs



























Anyone with a chronic medical problem knows how expensive drugs can be, and how a drug that you need can be here today … gone tomorrow on the list of drugs that your health plan will pay for. You also know that cost and insurance coverage aren’t the only factors in your choice.

Here’s your chance to let the drug czars, and others in the medical community, know how you decide which Multiple Sclerosis drugs to use, whether you think those drugs have helped you, and whether you actually have access to these drugs.

MS DMTs are being studied
The Institute for Clinical and Economic Review is in the process of reviewing Disease Modifying Therapies (DMTs), drugs like Avonex, Augabio and Tysabri. The Institute is a research group that tracks how well drugs and medical devices actually work. It then provides the evidence that it has collected to doctors, patients and everyone else in the healthcare system. For each of its reports, ICER provides an opportunity for stakeholders to be involved, and that’s where you come in.

Take an on-line survey
The Institute has joined with the MS Coalition, a group of nine MS organizations, to create an online survey for MS patients who use DMTs. The survey asks what DMTs you’ve used, how you chose them (doctor’s recommendation, cost, risk, effectiveness?) and whether there are things that have prevented you from using a drug that you wanted to use.

Once it’s finished collecting and analyzing its data, the researchers hope that health plans will use that data to develop or change their coverage polices for certain MS drugs, to the benefit of MS patients.

Story Source: The above story is based on materials provided by MULTIPLESCLEROSISNEWSTODAY
Note: Materials may be edited for content and length


Go to Newer News Go to Older News